According to their findings, a correlation between MBI and early Alzheimer's disease pathology was demonstrated for the first time through a set of cognitive assessments and brain imaging tests.
The findings were part of the Anti-Amyloid Treatment in Asymptomatic Alzheimer disease (A4) Study, an ongoing prevention trial with a primary objective of probing normal older adults with increased brain amyloid.
In their new study, released online in the peer-reviewed journal Nature, low-density lipoprotein receptor-related protein 1 (LRP1) was linked to the uptake and spread of tau in the brain.
A team of researchers at the University of California, San Diego unveiled a new PHGDH gene discovery that could pave the way for the development of a blood test for detecting Alzheimer's
A new study by Arizona State University explores the plausible theory of infectious pathogens or viruses triggering neurodegenerative illnesses, like Alzheimer’s disease. The findings appeared in the peer-reviewed journal Nature Reviews Neurology.
A research team funded by the National Institutes of Health made advancements in the development of a blood test able to predict Alzheimer's disease.
New research used EMR data to test the efficacy of machine learning algorithms in identifying patients at risk of dementia.
New research unveils a drug candidate of potential significance for combating the principle pathology of Alzheimer's disease.
According to new research, cellular senescence, a phenomenon recognized for its cessation of cell division, may lead to the development of neurodegenerative diseases.